SCHEMBL3408289

SCHEMBL3408289

NCC1CC=CN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15150018 1.00
SCHEMBL13594449 0.75
SCHEMBL10074740 0.74
SCHEMBL15150022 0.74
SCHEMBL13453019 0.74
SCHEMBL20125484 0.67
SCHEMBL2261878 0.65 IDO1 (0.35)
SCHEMBL15149745 0.64
SCHEMBL8300087 0.63
SCHEMBL14267433 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2257551-A2 AZATRICYCLIC ANTIBIOTIC COMPOUNDS Actelion Pharmaceuticals Ltd. (CH) 2010-12-08 EP disclosed
WO-2009104147-A2 AZATRICYCLIC ANTIBIOTIC COMPOUNDS ACTELION PHARMACEUTICALS LTD (CH) 2009-08-27 WO disclosed
EP-1635641-B1 MITOTIC KINESIN INHIBITORS MERCK & CO INC (US) 2009-03-25 EP disclosed
US-7427637-B2 Mitotic kinesin inhibitors MERCK & CO. INC. (US) 2008-09-23 US disclosed
EP-1635641-A4 MITOTIC KINESIN INHIBITORS MERCK & CO INC (US) 2006-12-20 EP disclosed
US-20060142278-A1 Mitotic kinesin inhibitors MERCK SHARP & DOHME CORP. 2006-06-29 US disclosed
EP-1635641-A2 MITOTIC KINESIN INHIBITORS Merck & Co., Inc. (US) 2006-03-22 EP disclosed
WO-2004112699-A2 MITOTIC KINESIN INHIBITORS MERCK & CO., INC. (US) 2004-12-29 WO disclosed